Evidence map›Paper›PMID 27402173›Full record

ArticleJournal of neurochemistry2016

Role of purinergic P2X4 receptors in regulating striatal dopamine homeostasis and dependent behaviors.

Sheraz Khoja, Vivek Shah, Damaris Garcia, Liana Asatryan, Michael W Jakowec, Daryl L Davies

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Modulation of P2XPhysiological reports · 2022
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Relationship betweenIranian journal of public health · 2021
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Cross-Talk between P2X and NMDA Receptors.International journal of molecular sciences · 2020
    Article
  16. Review
  17. Contribution of P2X4 Receptors to CNS Function and Pathophysiology.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sheraz KhojaDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California, USA.
Vivek ShahDepartment of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Damaris GarciaDepartment of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Liana AsatryanTitus Family Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California, USA.
Michael W JakowecDepartment of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Daryl L DaviesTitus Family Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California, USA. ddavies@usc.edu.
University of Southern California · US

Funding

Regulation of Alcohol Intake by Purinergic P2X4 ReceptorsR01AA022448 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI DAVIES, DARYL L · 2013 to 2020
$2.9M
NIAAA NIH HHS R01 AA022448
6 · The paper itself

Abstract

Purinergic P2X4 receptors (P2X4Rs) belong to the P2X superfamily of ion channels regulated by ATP. We recently demonstrated that P2X4R knockout (KO) mice exhibited deficits in sensorimotor gating, social interaction, and ethanol drinking behavior. Dopamine (DA) dysfunction may underlie these behavioral changes, but there is no direct evidence for P2X4Rs' role in DA neurotransmission. To test this hypothesis, we measured markers of DA function and dependent behaviors in P2X4R KO mice. P2X4R KO mice exhibited altered density of pre-synaptic markers including tyrosine hydroxylase, dopamine transporter; post-synaptic markers including dopamine receptors and phosphorylation of downstream targets including dopamine and cyclic-AMP regulated phosphoprotein of 32 kDa and cyclic-AMP-response element binding protein in different parts of the striatum. Ivermectin, an allosteric modulator of P2X4Rs, significantly affected dopamine and cyclic AMP regulated phosphoprotein of 32 kDa and extracellular regulated kinase1/2 phosphorylation in the striatum. Sensorimotor gating deficits in P2X4R KO mice were rescued by DA antagonists. Using the 6-hydroxydopamine model of DA depletion, P2X4R KO mice exhibited an attenuated levodopa (L-DOPA)-induced motor behavior, whereas ivermectin enhanced this behavior. Collectively, these findings identified an important role for P2X4Rs in maintaining DA homeostasis and illustrate how this association is important for CNS functions including motor control and sensorimotor gating. We propose that P2X4 receptors (P2X4Rs) regulate dopamine (DA) homeostasis and associated behaviors. Pre-synaptic and post-synaptic DA markers were significantly altered in the dorsal and ventral striatum of P2X4R KO mice, implicating altered DA neurotransmission. Sensorimotor gating deficits in P2X4R KO mice were rescued by DA antagonists. Ivermectin (IVM), a positive modulator of P2X4Rs, enhanced levodopa (L-DOPA)-induced motor behavior. These studies highlight potential interactions between P2X4Rs and DA system.

Indexed as

Behavior, AnimalAlcohol DrinkingAnimalsCorpus StriatumDopamineDopamine AgentsHomeostasisInterpersonal RelationsIvermectinLevodopaMaleMAP Kinase Signaling SystemMiceMice, Inbred C57BLMice, KnockoutMotor ActivityDopamineDopamine AgentsIvermectinLevodopaOxidopamineReceptors, Purinergic P2X46-OHDAdopamine receptorsIvermectinP2X4 receptorsParkinson's diseaseschizophrenia

Identifiers

PMID27402173
PMCPMC5037001
OpenAlexW2474368981

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.